Aster Capital Management’s Pfizer PFE Stock Holding History

Aster Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Buy	98,900 +65,455	+196%	+$1.74M	0.82%	27
2025 Q4	$833K	Buy	+33,445	New	+$843K	0.36%	45
2025 Q3	–	Sell	-20,113	Closed	-$488K	–	1276
2025 Q2	$488K	Buy	+20,113	New	+$469K	0.11%	222

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Aster Capital Management's PFE Position: Q1 2026 in Review

Aster Capital Management increased its Pfizer (PFE) stake by 196% in Q1 2026, buying an estimated $1.74M and bringing the position to 98,900 shares worth $2.51M. The position accounts for 0.82% of the portfolio, ranked #27.

Aster Capital Management first reported a position in PFE in Q2 2025 and has held it in 3 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Aster Capital Management held 98,900 shares of Pfizer worth $2.51M as of Q1 2026.
Aster Capital Management bought 65,455 Pfizer shares in Q1 2026, an estimated $1.74M.
Pfizer made up 0.82% of Aster Capital Management's portfolio in Q1 2026, its #27 holding.
Aster Capital Management first reported a position in Pfizer in Q2 2025 and has held it in 3 quarters since.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.